Novum is a full-service CRO with an impeccable performance record and numerous FDA approvals in new drug, 505(b)(2) and ANDA submissions.
Novum has managed complex studies across numerous therapeutic areas and dosage forms, spanning early phase to late phase trials. With the full integration of our bioanalytical unit in Toronto, Canada in 2020, Novum is poised to continue its longstanding tradition of serving clients with safety, quality, and scientific leadership.
"We have worked with Novum for almost 25 years and several items remain consistent throughout that time; best in class science, top notch communication and impeccable quality."
"Each individual project receives our full attention. Along with our top-class Project Management Team, we assign a member of our experienced Senior Leadership Team to each sponsor. This allow us to maintain the highest level of communication and keeps projects moving forward as planned."
Provide vital services to the pharmaceutical industry that advance the availability of quality medicine.
The safety and welfare of Novum study participants and employees trump all other concerns.
Ensure that our data, conduct, and actions are consistently handled with the utmost of integrity.
Go the extra mile to understand and respect other people: their points of view, their uniqueness, and their strengths.
Listen, anticipate, understand, and meet participant, customer and employee needs. Act with urgency.
Adapt to the needs of the market; embrace our strengths and be restless in our pursuit of new opportunities.
Create an environment where we share in successes and failures; always put Novum and its clients first.
Operate efficiently and effectively to foster strong financial results.
Contact a member of our team to speak about your unique study needs.
If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.